[Reduction of the Nordin index after therapy with oral alendronate in patients with postmenopausal osteoporosis].

The authors observe a significant reduction in value of the Nordin's Index (a sensible test for the screening of the "fast-losers" patients) in 10 women with post-menopausal osteoporosis after therapy with alendronate 5 mg daily per os for six months. The authors propound the measurement of the Nordin's Index in order to assess the alendronate's therapy per os in the post-menopausal osteoporosis.
AuthorsS Busi, A Catalano
JournalLa Clinica terapeutica (Clin Ter) Vol. 146 Issue 12 Pg. 857-9 (Dec 1995) ISSN: 0009-9074 [Print] ITALY
Vernacular TitleRiduzione dell'indice di Nordin dopo trattamento con alendronato per os in pazienti con osteoporosi post-menopausale.
PMID8681505 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Diphosphonates
  • Alendronate
  • Administration, Oral
  • Adult
  • Aged
  • Alendronate
  • Bone Density (drug effects)
  • Bone Resorption (drug therapy)
  • Diphosphonates (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: